Home Overview Press Room Blog Publications For Students about us
Search

About Assisted Reproduction


Most assisted reproductive technologies (ART) are used to treat infertility. Others are used when there are no fertility problems. Embryo screening or pre-implantation genetic diagnosis, for example, is used in order to prevent the births of children with specific genetic characteristics.

In vitro fertilization (IVF) refers to assisted reproduction procedures in which sperm and eggs are joined outside a woman's body. Women undergoing IVF are given hormonal drugs to promote the development of multiple eggs, which are retrieved with a minor surgical procedure. The eggs are mixed with sperm; one or more of those that fertilize are then transferred to the woman's uterus.

IVF has been in use since 1978 and has resulted in almost four million births worldwide. A number of IVF-related techniques have been introduced since then. Some of these, such as pre-implantation genetic diagnosis and commercial gestational surrogacy, raise significant ethical and policy concerns. In the United States alone, the assisted reproduction business is estimated to create over $3 billion in revenues a year.

Research on the risks associated with ART is notoriously inadequate. There have been few follow-up studies either on women who have used ARTs or their children. The United States is also known for having few laws governing assisted reproduction and little oversight of ART facilities.



French Luminaries’ Open Letter on Surrogacy by Marcy DarnovskyBiopolitical TimesJuly 24th, 2014Prominent left and center-left figures are urging President François Hollande to reinforce France’s legal prohibition of surrogacy contracts.
UK Move Toward “3-Person IVF” is Risky and Premature, Says Public Interest Group[Press statement]July 22nd, 2014The UK Department of Health has announced it will press ahead with efforts to gain Parliamentary approval for three-person IVF.
Cross-Border Surrogacy: Media Spotlight, EU Court Decision, International Forumby Marcy DarnovskyBiopolitical TimesJuly 10th, 2014What happens when people flout their own countries’ laws by going abroad to hire a surrogate in one of the few jurisdictions that allow it?
A Paragraph in Slow Motion: Three-Person IVF in The New York Timesby George Estreich, Biopolitical Times guest contributorJuly 10th, 2014A close look at the rhetoric used to justify experimental technologies, and particularly at the way reasonable objections are dismissed.
Donated IVF Eggs Linked to Gestational Hypertensionby Mitchel L. ZolerOb.Gyn. News Digital NetworkJuly 8th, 2014Women who became pregnant by in vitro fertilization with a donated egg had a substantially increased risk of pregnancy-induced hypertension and preeclampsia.
We're Already Designing Babies[With CGS's Marcy Darnovsky]by Olga KhazanThe AtlanticJuly 3rd, 2014Even today, parents are selecting for the traits they want in their offspring. But how far should the genetic tailoring go?
Should We Design Our Babies? [VIDEO] [With CGS's Marcy Darnovsky]The Aspen InstituteJuly 2nd, 2014At the Aspen Ideas Festival, Marcy Darnovsky and Nita A. Farahany discuss the possibility and implications of "designer babies."
Risks of Donor Egg Pregnancies Revealedby Laura DonnellyThe TelegraphJuly 1st, 2014A major study has found that women who become pregnant using donor eggs have far higher rates of complications.
Big Money Riding on the Hopes and Dreams of the Unwilling Childlessby Terry BarnesThe AgeJuly 1st, 2014Fertility clinics operate in an industry that is capable of exploiting those desperate to have children.
The Brave New World of Three-Parent I.V.F.[Quotes CGS's Marcy Darnovsky]by Kim TingleyNew York Times MagazineJune 27th, 2014The historic nature of the moment has turned the technique into a symbol, a red line separating humanity from a dystopian or progressive future, depending on how you look at it.
Displaying 1-10 of 998  
Next >> 
Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1936 University Ave, Suite 350, Berkeley, CA 94704 • • (p) 1.510.665.7760 • (F) 1.510.665.8760